Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Events
Resources
Search
Sunday, November 15, 2026
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
ReadMagazine Weekly Roundup: AI-Driven Energy, Enterprise Intelligence and Smarter Industrial Workflows
8 Top AI Software for Evaluating Scientific Papers
Fortreum Launches Kovr-Powered VDR/VER Ahead of FedRAMP Deadline
Tigo Energy and Google Cloud Join for AI Solar Tools
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Events
Resources
Home
Tags
Seaport Therapeutics
Seaport Therapeutics
Biotechnology
Seaport Therapeutics Secures $225M in Oversubscribed Series B Round
News Desk
-
October 22, 2024
Seaport Therapeutics, a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, announced the closing of an oversubscribed...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
ReadMagazine Weekly Roundup: AI-Driven Energy, Enterprise Intelligence and Smarter Industrial Workflows
8 Top AI Software for Evaluating Scientific Papers
Fortreum Launches Kovr-Powered VDR/VER Ahead of FedRAMP Deadline
Load more
